In a notable shift for investors, Henry Schein, Inc. (HSIC) recently garnered a ‘Buy’ rating from analyst David Larsen of BTIG on June 11, 2026. This recommendation comes with an optimistic price target of $100, suggesting a significant upside from the current trading price of $78.85. As investors weigh this endorsement, the implications for HSIC’s market positioning and future potential are poised to become a focal point for evaluation.
Recent Price Action
Henry Schein’s stock has exhibited a relatively stable trading pattern around the $78.85 mark, reflecting a minor increase of 0.03% during the last trading session. The company’s performance has been characterized by a high of $87.61 over the past year and a low of $34.53, positioning HSIC as a recovering entity within its sector. The stock’s market capitalization stands at approximately $8.99 billion, with a beta of 0.824, indicating a lower volatility relative to the broader market. Notably, trading volume recently reached 447,135 shares against an average of 1.36 million, further highlighting a cautious yet persistent investor interest in HSIC shares.
[chart type=’price’ value=’HSIC’]
Historical Performance
HSIC has demonstrated several interesting trends over the previous periods. Over the past 30 days, the stock has delivered a modest return of 1.46%, while the quarterly performance has been much more robust at 23.42%. Year-to-date, the stock has maintained an 8.33% increase. This upward trajectory is complemented by a weekly volatility of 2.89%, which raises slight concerns but reflects the stock’s ability to rebound. The average trading volume has hovered around 1.38 million shares over the last ten days, with a consistent three-month average of 1.38 million, indicating steady liquidity and investor engagement.
[chart type=’performance’ value=’HSIC’]
Earnings Analysis
Earnings performance further underscores the positive sentiment toward HSIC. Recently reported earnings per share (EPS) stood at $1.32, surpassing market expectations of $1.20 by a commendable 10%. This marks a continuation of a favorable earnings trend, following a previous EPS of $1.34 which also exceeded estimates. The ability to consistently meet or exceed earnings projections casts HSIC in a favorable light, reinforcing the underlying strength of the company’s financial health.
[chart type=’income-bar-chart’ value=’HSIC’]
Analyst Consensus View
The consensus among analysts echoes a growing optimism regarding HSIC’s future. With a total of six ratings compiled over the past 90 days, analysts assigned three ‘Buy’ ratings, two ‘Hold’ ratings, and one ‘Sell’ rating. The average price target has settled at approximately $86.83, with predictions ranging from a low of $64 to a high of $100. This distribution of ratings aligns well with the recent upgrade from BTIG, clearly suggesting that market participants generally anticipate a price rally in the coming months.
[chart type=’analyst-ratings’ value=’HSIC’]
Stock Grading or Fundamental View
The Stocks Telegraph Score for Henry Schein, Inc. stands at 48, a metric that captures the overall health and investment profile of the company. While the score indicates room for improvement, it also reflects a solid foundation based on financial and market analysis. The moderate score can be interpreted as a signal for investors: HSIC embodies strong fundamentals and demonstrates promise in innovation within the health care sector, making it one to watch for future developments.
[chart type=’st-cards’ value=’HSIC’]
Conclusion
For investors seeking exposure in the health care sector, Henry Schein, Inc. presents a compelling opportunity, particularly for those leaning towards growth-oriented strategies. The recent ‘Buy’ rating and the bullish price target showcased by analysts suggest HSIC is well-positioned for potential gains. However, it is essential for investors to consider the inherent risks, including market volatility and the stock’s historical performance fluctuations. The positive earnings surprise, combined with a generally favorable analyst sentiment, adds to the stock’s allure, marking it as a candidate for those looking for both defensive positions and growth potential in their portfolios.